Bristol-Myers Squibb: An Attractive High-Yield Stock Amid Market Uncertainty [Seeking Alpha]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Seeking Alpha
BMY's Growth Portfolio drove 16% YoY net sales growth, offsetting Legacy Portfolio declines; 2026 revenue guidance is $46–$47.5 billion with EPS of $6.05–$6.35. Technical support is seen in the mid-$50s, with fair value near $70 and long-term breakout potential to $85 if resistance at $63 is breached. Key risks include Eliquis patent expiration and pipeline execution, but high FCF yield and 20 recent EPS upgrades support the positive outlook. JHVEPhoto/iStock Editorial via Getty Images Bristol-Myers Squibb Company ( BMY ) has come under selling pressure recently, along with the State Street Health Care Select Sector SPDR ETF ( XLV ) and the S&P 500 Index ( SPX ). There's a bit of the baby being This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am n
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Stocks making big moves yesterday: Robinhood, Payoneer, Micron, Limbach, and Bristol-Myers Squibb [Yahoo! Finance]Yahoo! Finance
- Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb (BMY) Surpasses Market Returns: Some Facts Worth Knowing [Yahoo! Finance]Yahoo! Finance
- Why Bristol-Myers Squibb (BMY) Stock Is Up Today [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb (BMY) had its "hold (c)" rating reaffirmed by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 3/27/26 - Form 15-12G
- 3/26/26 - Form SCHEDULE
- 3/25/26 - Form ARS
- BMY's page on the SEC website